Clinical Trial Update: A Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating metronomic oral vinorelbine in combination with aromatase inhibitors for postmenopausal women with HR-positive, HER2-negative advance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromatase inhibitors (aromatase inhibitor)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Breast Cancer | Phase 3 | Status: TERMINATED